Treatment of schizophrenia and delusional disorder in the elderly

European Archives of Psychiatry and Clinical Neuroscience

Volumn 247, Issue 4, 1997, Pages 209-218

  Eastham, John H ^a   Jeste, Dilip V ^a  

^a NONE

Author keywords

Antipsychotics; Delusions; Dyskinesia; Geriatrics; Psychosis

Indexed keywords

ACETOPHENAZINE; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; RISPERIDONE; THIORIDAZINE; TIOTIXENE;

AKATHISIA; CONFUSION; DELUSION; DIFFERENTIAL DIAGNOSIS; DRUG POTENCY; DYSTONIA; ELECTROCONVULSIVE THERAPY; FALLING; HUMAN; HYPOTENSION; ONSET AGE; PARKINSONISM; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEDATION; SENESCENCE; SIDE EFFECT; TARDIVE DYSKINESIA;

EID: 0030766791     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02900217     Document Type: Review

References (70)

1. Jeste DV, Harris MJ, Krull A, Kuck J, McAdams LA, Heaton R (1995) Clinical and neuropsychological characteristics of patients with late-onset schizophrenia. Am J Psychiatry 152:722-730
2. Roth M (1995) The natural history of mental disorder in old age. J Ment Sci 101:281-301
3. Kay DWK, Roth M (1961) Environmental and hereditary factors in the schizophrenias of old age ("late paraphrenia") and their bearing on the general problem of causation in schizophrenia. J Ment Sci 107:649-686
4. Kay DWK, Beamish P, Roth M (1964) Old-age mental disorders in Newcastle-Upon-Tyne. Br J Psychiatry 110:146-158
5. Bleuler M (1943) Late schizophrenic clinical pictures. Fortschr Neurol Psychiatry 15:259-290
6. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, 3rd edn. American Psychiatric Press, Washington, DC
7. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (Dsm-III-R), 3rd edn, revised. American Psychiatric Press, Washington, DC
8. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
9. Maurer K, Häfner H (1995) Methodological aspects of onset assessment in schizophrenia. Schizophr Res 15:265-276
10. Harris MJ, Jeste DV (1988) Late-onset schizophrenia: an overview. Schizophr Bull 14:39-55
11. Corey-Bloom J, Jernigan T, Archibald S, Harris MJ, Jeste DV (1995) Quantitative magnetic resonance imaging in late-life schizophrenia. Am J Psychiatry 152:447-449
12. Ciompi L (1980) Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull 6:606-618
13. Winokur G (1977) Delusional disorder (paranoia). Compr Psychiatry 18:511-521
14. Kendler S, Davis KL (1981) The genetics and biochemistry of paranoid schizophrenia and other paranoid psychoses. Schizophr Bull 7:689-709
15. Gurian BS, Wexler D, Baker EH (1992) Late-life paranoia: possible association with early trauma and infertility. Int J Geriatr Psychiatry 7:277-284
16. Flint AJ, Rifat SI, Eastwood MR (1991) Late-onset paranoia: distinct from paraphrenia? Int J Geriatr Psychiatry 6:103-109
17. Miller BL, Benson FD, Cummings JL, Neshkes R (1986) Late-life paraphrenia: an organic delusional system. J Clin Psychiatry 47:204-207
18. Rockwell E, Krull AJ, Dimsdale J, Jeste DV (1994) Late-onset psychosis with somatic delusions. Psychosomatics 35:66-72
19. Evans JD, Paulsen JS, Harris MJ, Heaton RK, Jeste DV (1996) A clinical and neuropsychological comparison of delusional disorder and schizophrenia. J Neuropsychiatr Clin Neurosci 8: 281-286
20. Rowell FJ, Hui SM, Fairbairn AF, Eccleston D (1980) The effect of age and thioridazine on the in vitro binding of fluphenazine to normal human serum. Br J Clin Pharmacol 9:432-433
21. Honigfeld G, Rosebaum MP, Blumenthal IJ, Lambert HL, Roberts AJ (1965) Behavioral improvement in the older schizophrenic patient: drug and social therapies. J Am Geriatr Soc 13:57-71
22. Tsuang MM, Lu LM, Stotsky BA, Cole JO (1971) Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study. J Am Geriatr Soc 19:593-600
23. Branchey MH, Lee JH, Ramesh A (1978) High- and low-potency neuroleptics in elderly psychiatric patients. J Am Med Assoc 239:1860-1862
24. Rabins P, Pauker S, Thomas J (1984) Can schizophrenia begin after age 44? Compr Psychiatry 25:290-293
25. Jeste DV, Harris MJ, Pearlson GD, Rabins P, Lesser I, Miller B, Coles C, Yassa R (1988) Late-onset schizophrenia: studying clinical validity. Psychiatr Clin North Am 11:1-14
26. Jeste DV, Lacro JP, Gilbert PL, Kline J, Kline N (1993) Treatment of late-life schizophrenia with neuroleptics. Schizophr Bull 19 (4):817-830
27. Opjordsmoen J (1988) Hypochondriacal psychoses: a long-term follow-up. Acta Psychiatr Scand 77:587-597
28. McCoy LM, Schwarzkopf SB, Martin D (1992) Rapid response to pimozide in treatment resistant delusional disorder. Ann Clin Psychiatry 4:95-98
29. Ungvari GS, Hollokoi RIM (1993) Successful treatment of litigious paranoia with pimozide. Can J Psychiatry 38:4-8
30. Raskind M, Alvarez C, Herlin S (1979) Fluphenazine enthanthate in the outpatient treatment of late paraphrenia. J Am Geriatr Soc 27:459-463
31. Chiu HF (1995) Delusional jealousy in Chinese elderly psychiatric patients. J Geriatr Psychiatry Neurol 8:49-51
32. Songer DA, Roman B (1996) Treatment of somatic delusional disorder with atypical antipsychotic agents. Am J Psychiatry 153:578-579
33. Oberholzer AF, Hendriksen C, Monsch AU, Heierli B, Stahelin HB (1992) Safety and effectiveness of low-dose clozapine in psychogeriatric patients: a preliminary study. Int Psychogeriatr 4:187-195
34. Chengappa KNR, Baker RW, Kreinbrock SB, Adair D (1995) Clozapine use in female geriatric patients with psychoses. J Geriatr Psychiatry Neurol 8:12-15
35. Salzman C, Vacarro B, Lieff J, Weiner A (1995) Clozapine in older patients with psychosis and behavioral disruption. Am J Geriatr Psychiatry 3:26-33
36. Pitner JK, Mintzer JE, Pennypacker LC, Jackson CW (1995) Efficacy and adverse effects of clozapine in four elderly psyschotic patients. J Clin Psychiatry 56:180-185
37. Borison RL, Davidson M, Berman I (1994) Risperidone treatment in elderly patients with schizophrenia or dementia (Poster). APA 46th Institute of Hospital and Community Psychiatry (Abstract)
38. Jeste DV, Eastham JH, Lacro JP, Gierz M, Field MG, Harris MJ (1996) Management of late-life psychosis. J Clin Psychiatry 57:39-45
39. Jeste DV, Eastham JH, Gierz M, Field MG, Morgenstern M, Lacro JP (1997) Use of risperidone in the elderly. In: Ayd F (ed) The art of rational risperidone therapy. Ayd Medical Communications, Baltimore, pp 147-167
40. Berman I, Merson A, Rachov-Pavlov J, Allan E, Davidson M, Losonczy MF (1996) Risperidone in elderly schizophrenic patients. Am J Geriatr Psychiatry 4:173-179
41. Stip E, Lussier I (1996) The effect of risperidone on cognition in patients with schizophrenia. Can J Psychiatry 41:35S-40S
42. Frankenburg FR, Kalunian D (1994) Clozapine in the elderly. J Geriatr Psychiatry Neurol 7:129-132
43. Madhusoodanan S, Brenner R, Araujo L, Abaza A (1995) Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J Clin Psychiatry 56:514-518
44. Sajatovic M, Ramirez LF, Vernon L, Brescan D, Simon M, Jurjus G (1996) Outcome of risperidone therapy in elderly patients with chronic psychosis. Int J Psychiatry Med 26:309-317
45. Levy RH (1996) Sedation in acute and chronic agitation. Pharmacotherapy 16:152S-159S
46. Tune LE, Bylsma FW (1991) Benzodiazepinie-induced and anticholinergic-induced delirium in the elderly. Int Psychogeriatrics 3:397-408
47. Thienhaus OJ, Allen A, Bennett JA, Chopra YM, Zemlan FP (1990) Anticholinergic serum levels and cognitive performance. Eur Arch Psychiatry Clin Neurosci 240:28-33
48. Tollefson G, Montague-Clouse J, Lancaster SP (1991) The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population. J Neuropsychiatr Clin Neurosci 3:314-319
49. Tune L, Carr S, Hoag E, Cooper T (1992) Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry 149 (10):1393-1394
50. Ames D, Wirshing WC, Marder SR (1996) Advances in antipsychotic pharmacotherapy: clozapine, risperidone, and beyond. Essent Psychopharmacol 1:5-26
51. Gershanik OS (1994) Drug-induced parkinsonism in the aged. Drugs Aging 5:127-132
52. Campbell AJ (1991) Drug treatment as a cause of falls in old age: a review of the offending agents. Drugs Aging 1:289-302
53. Kane JM, Jeste DV, Barnes TRE, Casey DE, Cole JO, Davis JM, Gualtieri CT, Schooler NR, Sprague RL, Wettstein RM (1992) Tardive dyskinesia: a Task Force Report of the American Psychiatric Association. American Psychiatric Association, Washington, DC
54. Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris MJ, Bailey A, Fell RL, McAdams LA (1995) Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 patients. Arch Gen Psychiatry 52:756-765
55. Eastham JH, Lacro JP, Jeste DV (1996) Ethnicity and movement disorders. Mt Sinai J Med 63(5/6):314-319
56. Caligiuri MP, Lacro JP, Rockwell E, McAdams LA, Jeste DV (1997) Incidence and risk factors for severe tardive dyskinesia in older patients. Br J Psychiatry (in press)
57. Lohr LB, Browning JA (1995) Free radical involvement in neuropsychiatry illnesses. Psychopharmacol Bull 31:159-165
58. Stimmel GL (1996) Benzodiazepines in schizophrenia. Pharmacotherapy 16:1488-1518
59. Lerner Y, Mintzer Y, Schestatzky M (1988) Lithium combined with haloperidol in schizophrenic patients. Br J Psychiatry 153: 359-362
60. Terao T, Oga T, Nozaki S, Ohta A, Ohtsubo Y, Yamamoto S, Zamami M, Okada M (1995) Lithium addition to neuroleptic treatment in chronic schizophrenia: a randomized, double-blind, placebo-controlled, cross-over study. Acta Psychiatr Scand 92: 220-224
61. Miller F, Menninger J, Whitcup SM (1986) Lithium-neuroleptic neurotoxicity in the elderly bipolar patient. J Clin Psychopharmacol 6:176-178
62. Pary R, Tobias CR, Lippmann S (1995) Chronic schizophrenia. Options for pharmacologie management. Postgrad Med 98: 163-173
63. Morinigo A, Martin J, Golzalez S, Mateo I (1989) Treatment of resistant schizophrenia with valproate and neuroleptic drugs. Hillside J Clin Psychiatry 11:199-207
64. Altamura AC, Basile R, Mauri M, Cazzullo CL (1986) Valpromide (Depamide) in the treatment of acute psychotic states. Open clinical study. Acta Psychiatr Belg 86:297-304
65. Weiden P, Rapkin B, Mott T, Zygmunt A, Goldman D, Horvitz-Lennon M, Frances A (1994) Rating of medication influences (ROMI) scale in schizophrenia. Schizophr Bull 20:297-310
66. Patterson LE (1996) Strategies for improving medication compliance. Essent Psychopharmacol 1:70-79
67. Remington GJ, Jeffries JJ (1994) Erotomanie delusions and electroconvulsive therapy: a case series. J Clin Psychiatry 55: 306-308
68. Wolters EC, Jansen ENH, Tuynman-Qua HG, Bergmans PLM (1996) Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease. Neurology 47: 1085-1087
69. Buckley P, Cutler N, Silber C, O'Neil J, Mack R (1997) The safety and tolerability of sertindole in elderly patients with dementia. Schizophr Res 24:201
70. Tariot PN, Arvanitis LA (1997) Efficacy, safety, and tolerability of quetiapine in elderly subjects with psychotic disorders. Abstracts of the American Association of Geriatric Psychiatry 10th Annual Meeting and Symposium, Orlando, Fla 88